Managing Multiple Diseases: Renal Dysfunction Cases - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

Managing Multiple Diseases: Renal Dysfunction Cases

Description:

Laboratory Evaluation: CD4 220 cell/mm3. Viral load 50 copies/ mL ... The patient is 130 lbs. Based on his serum creatinine, his calculated creatinine ... – PowerPoint PPT presentation

Number of Views:81
Avg rating:3.0/5.0
Slides: 17
Provided by: mik87
Category:

less

Transcript and Presenter's Notes

Title: Managing Multiple Diseases: Renal Dysfunction Cases


1
Managing Multiple DiseasesRenal Dysfunction
Cases
  • Todd S. Wills, MD
  • Assistant Professor of Internal Medicine
  • Division of Infectious Diseases and International
    Medicine
  • University of South Florida College of Medicine

2
Disclosure of Financial Relationships
  • This speaker has no significant financial
    relationships with commercial entities to
    disclose.

This slide set has been peer-reviewed to ensure
that there are no conflicts of interest
represented in the presentation.
3
  • 39 year old male presents for initiation of
    antiretroviral therapy
  • History of IV drug use
  • PMH HTN, hyperlipidemia, depression, anxiety,
    HCV Ab
  • CD4 130 cell/mm3
  • Viral Load 75,000 copies/ mL
  • CBC normal, BUN 14, Cr 0.9 mg/dL

4
  • Which of the following antiretroviral regimens is
    the best choice for this patient?
  • A.) D4T/3TC/Lopinavir-ritonavir
  • B.) D4T/ABC/Efavirenz
  • C.) Emtricitabine/tenofovir/atazanavir
  • D.) Emtricitabine/tenofovir/atazanavir/ritonavir

5
  • A.) D4T/3TC/Lopinavir-ritonavir
  • B.) AZT/ABC/Efavirenz
  • C.) Emtricitabine/tenofovir/atazanavir
  • D.) Emtricitabine/tenofovir/atazanavir/ritonavir

6
  • At 6 month follow-up, he is 100 adherent with
    prescribed therapy
  • Laboratory Evaluation
  • CD4 220 cell/mm3
  • Viral load lt 50 copies/ mL
  • BUN 26, Cr 2.1mg/dL, PO4 1.8 mg/dL

7
  • Which drug is not implicated in his renal
    insufficiency?
  • A.) Tenofovir
  • B.) Emtricitabine
  • C.) Atazanavir
  • D.) Ritonavir

8
  • A.) Tenofovir
  • B.) Emtricitabine
  • C.) Atazanavir
  • D.) Ritonavir

9
  • What percentage of patients taking tenofovir
    suffer severe renal impairment (GFR lt 30 mL/min)?
  • A.) 0-3
  • B.) 5-10
  • C.) 20
  • D.) gt30

10
  • A.) 0-3
  • B.) 5-10
  • C.) 20
  • D.) gt30

11
  • What percentage of patients taking tenofovir
    suffer mild renal impairment (GFR 60-89 mL/min)?
  • A.) 0-3
  • B.) 5-10
  • C.) 20
  • D.) gt30

12
  • A.) 0-3
  • B.) 5-10
  • C.) 20
  • D.) gt30

13
  • The patient is changed to 3TC, Abacavir, and
    boosted atazanavir. Is dose adjustment
    necessary?
  • A.) Yes
  • B.) No
  • C.) Need More Information

14
  • A.) Yes
  • B.) No
  • C.) Need More Information

15
  • The patient is 130 lbs. Based on his serum
    creatinine, his calculated creatinine clearance
    is 39 mL/ minute. Which antiretroviral should be
    adjusted?
  • A.) Abacavir
  • B.) 3TC
  • C.) Atazanavir
  • D.) Ritonavir

16
  • A.) Abacavir
  • B.) 3TC
  • C.) Atazanavir
  • D.) Ritonavir
Write a Comment
User Comments (0)
About PowerShow.com